Jeff Yass’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.6K Buy
+30,905
New +$60.8K ﹤0.01% 12735
2026
Q1
Sell
-212,659
Closed -$500K 13863
2025
Q4
$500K Buy
+212,659
New +$409K ﹤0.01% 8786
2019
Q1
Sell
-1
Closed -$22K 9567
2018
Q4
$22K Buy
+1
New +$57.4K ﹤0.01% 8665
2018
Q1
Hold
0
9939
2017
Q4
Hold
0
8971
2017
Q3
Hold
0
8645
2017
Q2
Sell
-1
Closed -$439K 9642
2017
Q1
$470K Buy
+1
New +$381K ﹤0.01% 6584
2016
Q4
Hold
0
-$6K 9978
2016
Q3
Hold
0
8301
2016
Q2
Hold
0
8448
2016
Q1
Hold
0
8521
2015
Q4
Hold
0
8857
2015
Q3
Sell
-1
Closed -$1.84M 8235
2015
Q2
$1.72M Buy
+1
New +$2.18M ﹤0.01% 5038
2015
Q1
Hold
0
7206
2014
Q4
Hold
0
6637
2014
Q3
Hold
0
7550
2014
Q2
Hold
0
6723
2014
Q1
Hold
0
4554
2013
Q4
Hold
0
-$29K 9208
2013
Q3
Hold
0
8294

Other funds holding PALI

Jeff Yass's PALI Position: Q2 2026 in Review

Jeff Yass opened a new position in Palisade Bio (PALI) in Q2 2026: 30,905 shares worth $64.6K. The stake represents ﹤0.01% of the portfolio and ranks #12735 among its holdings. This is a return to the name: Jeff Yass previously reported a position in PALI as recently as Q4 2025.

Jeff Yass first reported a position in PALI in Q2 2015 and has held it in 5 quarters since. The position peaked at $1.72M in Q2 2015. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Jeff Yass held 30,905 shares of Palisade Bio worth $64.6K as of Q2 2026.
  • Palisade Bio was a new Jeff Yass position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12735 holding.
  • Jeff Yass first reported a position in Palisade Bio in Q2 2015 and has held it in 5 quarters since.
  • Jeff Yass's Palisade Bio position peaked at $1.72M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.